Drug intelligence / Profile preview

oxibendazole

Development stage
Unknown
Modality
Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Oxibendazole is a benzimidazole-class anthelmintic drug primarily used in veterinary medicine to treat and prevent infestations by roundworms, strongyles, threadworms, pinworms, and lungworm in horses and other domestic animals[2][4][5]. It acts as a small molecule polymerase inhibitor. The mechanism of action involves binding to the colchicine-sensitive site of β-tubulin in parasitic cells, inhibiting microtubule polymerization. This disruption impairs glucose uptake and depletes glycogen stores in the parasite, leading to energy depletion (decreased ATP production), paralysis, and death[1][6][7][8]. Oxibendazole is poorly absorbed orally; most remains in the gastrointestinal tract where it exerts its effect on gut-dwelling parasites[8]. It undergoes hepatic metabolism. While widely used for animals, it has also been investigated for human use against helminth intestinal infections (phase III trials)[1][3].

Other names
methyl-5-n-propoxy-2-benzimidazole-carbamatemethyl5-n-propoxy-2-benzimidazole-carbamatemethyl 5-n-propoxy-2-benzimidazole-carbamateOBZ
02

Targets

TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on oxibendazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxibendazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call